“shire-human-genetic-therapies” Archives

Entry Author Date Location
Pappas, Chiesi Venture Fund Joins Ranks of Pharma & VC Partnerships 09/10/14 Raleigh Durham
Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO 05/15/12 Boston
Atlas Venture, Shire to Create Startups to Tackle Rare Diseases 12/15/11 Boston
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News 06/10/11 Boston
BMS & Others Partner with WPI 06/09/11 Boston
Synageva Grabs $25M for Rare Diseases Drug Pipeline 03/21/11 Boston
Edimer, Third Rock’s Bet on Rare Diseases, Aims to Begin First Human Tests 03/15/11 Boston
With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche 03/03/11 Boston
Acceleron Weans Itself Off VC, Continues its Roll with Pharma Partner Dollars 09/28/10 Boston
Biogen Idec Board in Flux, Cubist Acquires Calixa, ImmunoGen Drug Passes Clinical Test, & More Boston-Area Life Sciences News 12/16/09 Boston
Genzyme Rival Seeks European Approval 11/24/09 Boston
Another Genzyme Rival Advancing 09/01/09 Boston
FDA Committee Votes in Favor of Dyax Lead Drug for Rare Blood Disease 02/04/09 Boston
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News 11/26/08 Boston
Shire HGT Adds 150 Mass. Workers, Genetic Therapy Sales Soar, President Says 11/20/08 Boston
Page 1 of 1